IGF2BP1 and melanoma: These findings are consistent with previous research showing that IGF2BP1 knockout inflamed the tumor microenvironment by increasing NK cells and tumor-associated myeloid cells 45 and that high IGF2BP1 and IGF2BP3 levels are associated with immunotherapy resistance in melanoma patients 45.